Aliskiren/amlodipine (combination of active ingredients) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)

Report documents

1. Extract of dossier assessment

   Aliskiren/amlodipine (combination of active ingredients) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)

   published on

   15.02.2012

   Document type

   PDF document, 55 kB, EN, not accessible

   Download file : Extract of dossier assessment (PDF document, 55 kB, EN, not accessible)
2. Dossier assessment

   Aliskiren/amlodipine (combination of active ingredients) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)

   published on

   15.02.2012

   Document type

   PDF document, 215 kB, DE, not accessible

   Download file : Dossier assessment (PDF document, 215 kB, DE, not accessible)

Press releases

Additional information

Project details

Project no.

A11-29

Commission

Commission awarded on 14.11.2011 by the Federal Joint Committee (GBA).

Report type

Dossier assessment

Status

Commission completed

Department/Division

Drug Assessment

Topic

Heart and circulation

Note

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.

Connected Projects

1. Dossier assessment

   Aliskiren/amlodipine (combination of active ingredients) - Consultation on the content and completeness of the dossier

   Project no.

   A11-09

   Last updated

   03.08.2011

   Status: Commission completed